Dermatol. praxi. 2009;3(4):188-190

The SAPHO syndrome

MUDr.Lucie Růžičková Jarešová, MUDr.Alena Machovcová, MBA
Dermatovenerologické oddělení, FN Motol, Praha
Ústav estetické medicíny, Praha

The SAPHO syndrome was described for the first time by the French dermatology institute in 1877 (1). It deals with coincidence of the

dermatic and bony-arthral signs. The etiology is unknown. It shows symptoms in most cases in the period of adolescence. There are

used to the general therapy antharthritic, retinoids, antibiotics and corticosteroid. Locally there are applied external middles in conformity

with the dermatic infliction.

In the note is described the case of 17 years old boy. He had been monitored since 2006 and after that he has been treated because of the

aggravation of acne with the gradual progress of bony and arthral infliction. The improvement came after the general combined therapy

by corticosteroids and retinoids and by transplantation of the skin on chest.

Keywords: SAPHO syndrome, clinical manifestations, local and total treatment

Published: May 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Růžičková Jarešová L, Machovcová A. The SAPHO syndrome. Dermatol. praxi. 2009;3(4):188-190.
Download citation

References

  1. Chamot AM, Benhamour CL. Is difuse sclerosing osteomyelitis of the mandibule part of the synovitis, acne, pustulosis, hyperostosis (SAPHO) syndrome? Analysis of seven cases. Oral Surg. 1994; 78(5): 594-598. Go to original source... Go to PubMed...
  2. Kahn MF. SAPHO. Rheum. Eur. 1996; 25(1): 24-26. Go to original source...
  3. Kahn MF. Psoriatic arthritis and synovitis, acne, pustulosis, hyperostosis and osteitis. Current Opinion in Rheumatology 1993; 5: 428-435. Go to original source... Go to PubMed...
  4. Perrot S, Job-Deslandre C, Mevorach D. Seven cases of chronic multifocal osteomyelitis or pediatric SAPHO syndrome. J. Orthop. Rheum. 1996; 9(3): 123-127.
  5. Wagner AD, Andresen J, Jendro MC, et al. Sustained response to tumor necrosis factor alpha-blocking agents in two patients with SAPHO syndrome. Arthritis Rheumat 2002; 46: 1965-1968. Go to original source... Go to PubMed...
  6. Štork J, et al. Dermatovenerologie. Praha: Galén, 2008.




Dermatology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.